{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:23:58Z","timestamp":1787689438401,"version":"build-2784847793"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2404602"],"award-info":[{"award-number":["2022YFC2404602"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.prro.2026.06.008","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T07:00:20Z","timestamp":1783407620000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Locoregional Recurrence Patterns and Prognostic Outcomes in Early-Stage Natural Killer\/T-Cell Lymphoma Treated With Sandwich Chemoradiation Therapy: A Post Hoc Analysis of a Randomized Controlled Trial"],"prefix":"10.1016","author":[{"given":"Shu-Bei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Guo","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Min","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Juan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8071-4422","authenticated-orcid":false,"given":"Gang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2026.06.008_bib0001","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1002\/cncr.30697","article-title":"The impact of the omission or inadequate dosing of radiotherapy in extranodal natural killer T-cell lymphoma, nasal type, in the United States","volume":"123","author":"Vargo","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2026.06.008_bib0002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2018.04.026","article-title":"Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK\/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG)","volume":"129","author":"Deng","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2026.06.008_bib0003","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2005.03.2573","article-title":"Radiotherapy as primary treatment for stage IE and IIE nasal natural killer\/T-cell lymphoma","volume":"24","author":"Li","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2026.06.008_bib0004","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1001\/jamaoncol.2016.5094","article-title":"Association of improved locoregional control with prolonged survival in early-stage extranodal nasal-type natural killer\/T-cell lymphoma","volume":"3","author":"Yang","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.prro.2026.06.008_bib0005","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.1002\/cam4.1755","article-title":"Promising clinical outcomes of sequential and \"Sandwich\" chemotherapy and extended involved-field intensity-modulated radiotherapy in patients with stage I(E) \/II(E) extranodal natural killer\/T-cell lymphoma","volume":"7","author":"Wang","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.prro.2026.06.008_bib0006","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1080\/10428194.2018.1563690","article-title":"Differential clinical significance of pre-, interim-, and post-treatment plasma Epstein-Barr virus DNA load in NK\/T-cell lymphoma treated with P-GEMOX protocol","volume":"60","author":"Wang","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.prro.2026.06.008_bib0007","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1470-2045(15)00533-1","article-title":"A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: A multicentre, retrospective analysis","volume":"17","author":"Kim","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2026.06.008_bib0008","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41375-020-0791-3","article-title":"Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK\/T-cell lymphoma in the modern chemotherapy era: Indication for prognostication and clinical decision-making","volume":"35","author":"Chen","year":"2021","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.prro.2026.06.008_bib0009","first-page":"100426","article-title":"Etoposide, dexamethasone, and pegaspargase with sandwiched radiotherapy in early-stage natural killer\/T-cell lymphoma: A randomized phase III study","volume":"4","author":"Zhong","year":"2023","journal-title":"Innovation (Camb)"},{"key":"10.1016\/j.prro.2026.06.008_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","article-title":"Modern radiation therapy for extranodal lymphomas: Field and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"92","author":"Yahalom","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.06.008_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100206","article-title":"Association of improved overall survival with decreased distant metastasis following asparaginase-based chemotherapy and radiotherapy for intermediate- and high-risk early-stage extranodal nasal-type NK\/T-cell lymphoma: A CLCG study","volume":"6","author":"Zheng","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.prro.2026.06.008_bib0012","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijrobp.2016.09.013","article-title":"Patterns of primary tumor invasion and regional lymph node spread based on magnetic resonance imaging in early-stage nasal NK\/T-cell lymphoma: Implications for clinical target volume definition and prognostic significance","volume":"97","author":"Wu","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.06.008_bib0013","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood-2003-05-1401","article-title":"Primary nasal natural killer cell lymphoma: Long-term treatment outcome and relationship with the International Prognostic Index","volume":"103","author":"Chim","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.prro.2026.06.008_bib0014","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1002\/cncr.26167","article-title":"Failure patterns and clinical implications in early stage nasal natural killer\/T-cell lymphoma treated with primary radiotherapy","volume":"117","author":"Li","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2026.06.008_bib0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0167-8140(01)00428-5","article-title":"Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck","volume":"61","author":"Kim","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2026.06.008_bib0016","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.ijrobp.2023.09.031","article-title":"Phase 2 clinical trial of simultaneous boost intensity modulated radiation therapy with 3 dose gradients in patients with stage I-II nasal type natural killer\/T-cell lymphoma: Long-term outcomes of survival and quality of life","volume":"118","author":"Niu","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.06.008_bib0017","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.ijrobp.2013.08.040","article-title":"High-dose and extended-field intensity modulated radiation therapy for early-stage NK\/T-cell lymphoma of Waldeyer's ring: Dosimetric analysis and clinical outcome","volume":"87","author":"Bi","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.06.008_bib0018","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12032-014-0320-1","article-title":"Prophylactic cervical lymph node irradiation provides no benefit for patients of stage IE extranodal natural killer\/T cell lymphoma, nasal type","volume":"32","author":"Wang","year":"2015","journal-title":"Med Oncol"},{"key":"10.1016\/j.prro.2026.06.008_bib0019","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ijrobp.2003.12.006","article-title":"Angiocentric T-cell and NK\/T-cell lymphomas: Radiotherapeutic viewpoints","volume":"59","author":"Koom","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.06.008_bib0020","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ijrobp.2021.02.011","article-title":"Modern radiation therapy for extranodal nasal-type NK\/T-cell lymphoma: Risk-adapted therapy, target volume, and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"110","author":"Qi","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.06.008_bib0021","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejca.2022.07.023","article-title":"Timing of postmastectomy radiotherapy following adjuvant chemotherapy for high-risk breast cancer: A post hoc analysis of a randomised controlled clinical trial","volume":"174","author":"Chen","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.prro.2026.06.008_bib0022","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13014-016-0671-1","article-title":"Optimal timing of salvage radiotherapy for biochemical recurrence after radical prostatectomy: Is ultra-early salvage radiotherapy beneficial?","volume":"11","author":"Taguchi","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2026.06.008_bib0023","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.wneu.2015.03.052","article-title":"Optimal timing of whole-brain radiation therapy following craniotomy for cerebral malignancies","volume":"84","author":"Patel","year":"2015","journal-title":"World Neurosurg"},{"key":"10.1016\/j.prro.2026.06.008_bib0024","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/mrm.28990","article-title":"Assessment of the effects of mimicking tissue microstructural properties on s and apparent exchange rate in diffusion MRI via a series of specially designed phantoms","volume":"87","author":"Li","year":"2022","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.prro.2026.06.008_bib0025","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1148\/radiol.2432060450","article-title":"Malignant supratentorial astrocytoma treated with postoperative radiation therapy: Prognostic value of pretreatment quantitative diffusion-weighted MR imaging","volume":"243","author":"Murakami","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.prro.2026.06.008_bib0026","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/jhbp.732","article-title":"Prognostic prediction of apparent diffusion coefficient obtained by diffusion-weighted MRI in mass-forming intrahepatic cholangiocarcinoma","volume":"27","author":"Yamada","year":"2020","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.prro.2026.06.008_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.3458","article-title":"Diffusion MRI in early cancer therapeutic response assessment","volume":"30","author":"Galb\u00e1n","year":"2017","journal-title":"NMR Biomed"},{"key":"10.1016\/j.prro.2026.06.008_bib0028","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.31557\/APJCP.2022.23.7.2449","article-title":"The role of pretherapeutic diffusion-weighted MR imaging derived apparent diffusion coefficient in predicting clinical outcomes in immunocompetent patients with primary CNS lymphoma: A systematic review and meta-analysis","volume":"23","author":"Mulyadi","year":"2022","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.prro.2026.06.008_bib0029","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5045\/br.2020.2020032","article-title":"Apparent diffusion coefficient as a valuable quantitative parameter for predicting clinical outcomes in patients with newly diagnosed primary CNS lymphoma","volume":"55","author":"Baek","year":"2020","journal-title":"Blood Res"},{"key":"10.1016\/j.prro.2026.06.008_bib0030","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/annonc\/mdx684","article-title":"Sequential chemotherapy\/radiotherapy was comparable with concurrent chemoradiotherapy for stage I\/II NK\/T-cell lymphoma","volume":"29","author":"Kwong","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.prro.2026.06.008_bib0031","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ajh.25878","article-title":"Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK\/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study","volume":"95","author":"Qi","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.prro.2026.06.008_bib0032","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1080\/10428194.2020.1811864","article-title":"Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population","volume":"61","author":"Ghione","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.prro.2026.06.008_bib0033","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ebiom.2017.10.011","article-title":"A phase II study of methotrexate, etoposide, dexamethasone and pegaspargase sandwiched with radiotherapy in the treatment of newly diagnosed stage IE to IIE extranodal natural-killer\/T-Cell lymphoma, Nasal-Type","volume":"25","author":"Xu","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.prro.2026.06.008_bib0034","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1200\/JCO.2009.23.8295","article-title":"Phase I\/II study of concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211","volume":"27","author":"Yamaguchi","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2026.06.008_bib0035","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1200\/JCO.2009.23.8592","article-title":"Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK\/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study","volume":"27","author":"Kim","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2026.06.008_bib0036","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/ajh.26335","article-title":"Sequential P-GEMOX and radiotherapy for early-stage extranodal natural killer\/T-cell lymphoma: A multicenter study","volume":"96","author":"Zhang","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.prro.2026.06.008_bib0037","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","year":"1993","journal-title":"N Engl J Med"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850026002031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850026002031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:10:27Z","timestamp":1787688627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850026002031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"alternative-id":["S1879850026002031"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2026.06.008","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Locoregional Recurrence Patterns and Prognostic Outcomes in Early-Stage Natural Killer\/T-Cell Lymphoma Treated With Sandwich Chemoradiation Therapy: A Post Hoc Analysis of a Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2026.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}]}}